Log in

Sleep in obsessive compulsive disorder

Polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Several lines of evidence suggest that brain serotonergic systems may be disturbed in obsessive compulsive disorder (OCD). The serotonergic system strongly affects sleep and characteristic abnormalities of sleep are documented in depression. This study, therefore, aimed to investigate sleep structure of OCD patients in order to evaluate whether similar changes as in depression are present. Up to now, this issue has been addressed only in few studies with small numbers of patients. Sleep patterns of 62 unmedicated patients with primary OCD and 62 age- and sex-matched healthy controls were investigated by polysomnography. Additionally, the impact of tryptophan depletion on sleep was studied in a subgroup of 12 OCD patients and 12 controls. The OCD patients exhibited moderate, but significant disturbances of sleep continuity measures but no abnormalities of slow wave sleep or REM sleep, except a significant elevation of 1st REM density. Tryptophan depletion induced a worsening of sleep continuity, but no changes of REM sleep or slow wave sleep. Assuming that changes of sleep architecture indicate underlying neurobiological abnormalities, this study indicates that neurobiological disturbances are different in primary OCD as compared with primary depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, Rossler W (2004) Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci 254:156–164

    PubMed  Google Scholar 

  2. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Blair Simpson H, Tu X (2005) Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162:151–161

    Article  PubMed  Google Scholar 

  3. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ (1998) Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology 136:205–216

    Article  PubMed  CAS  Google Scholar 

  4. Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Rauchle H, Hohagen F (2005) Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 255:48–50

    Article  PubMed  Google Scholar 

  5. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H (2005) Long–term course and outcome of obsessive–compulsive patients after cognitive–behavioral therapy in combination with either fluvoxamine or placebo: A 7–year follow–up of a randomized double–blind trial. European Archives of Psychiatry and Clinical Neuroscience 255:121–128

    Article  PubMed  Google Scholar 

  6. Saxena S, Rauch SL (2000) Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Pediatric Clinics of North America 23:563–586

    Article  CAS  Google Scholar 

  7. Kuelz A, Hohagen F, Voderholzer U (2004) Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biological Psychology 65:185–236

    Article  PubMed  Google Scholar 

  8. Moritz S, Jacobsen D, Willenborg B, Jelinek L, Fricke S (2006) A check on the memory deficit hypothesis of obsessive–compulsive checking. European Archives of Psychiatry and Clinical Neuroscience 256:82–86

    Article  PubMed  Google Scholar 

  9. Murphy DL, Greenberg B, Altemus M, Benjamin J, Grady T, Pigott T (1996) The Neuropharmacology and Neurobiology of Obsessive-compulsive Disorder. In: Westenberg HGM (ed). Advances in the Neurobiology of Anxiety Disorders. John Wiley & Sons Ltd., Chichester, pp 279–297

    Google Scholar 

  10. Pigott TA, Seay SM (1999) A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 60:101–106

    PubMed  CAS  Google Scholar 

  11. Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L’Heureux F, Murphy DL (1998) Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results. Psychiatry Res 79:11–20

    Article  PubMed  CAS  Google Scholar 

  12. Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Am J Psychiatry 145:1015–1017

    PubMed  CAS  Google Scholar 

  13. Zohar J, Mueller EA, Insel TR, Zohar Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44:946–951

    PubMed  CAS  Google Scholar 

  14. Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR (1989) Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Arch Gen Psychiatry 46:23–28

    PubMed  CAS  Google Scholar 

  15. Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, Lee DS, Lee MC (2003) Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 107:291–297

    Article  PubMed  Google Scholar 

  16. Stengler-Wenzke K, Muller U, Angermeyer MC, Sabri O, Hesse S (2004) Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci 254:252–255

    PubMed  Google Scholar 

  17. Swedo SE, Leonard JL, Kruesi MJ, Rettew DC, Listwak SJ, Berrettini W, Stipetic M, Hamburger S, Gold PW, Potter WZ (1992) Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 49:29–36

    PubMed  CAS  Google Scholar 

  18. Baumgarten HG, Grozdanovic Z (1998) Role of serotonin in obsessive-compulsive disorder. Brit J Psychiatry 173 (Suppl. 35):13–20

    Google Scholar 

  19. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH (1994) Tryptophan depletion in patients with obsessive compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 51:309–317

    PubMed  CAS  Google Scholar 

  20. Smeraldi E, Diaferia G, Erzegovesi S, Lucca A, Bellodi L, Moja EA (1996) Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry 40:398–402

    Article  PubMed  CAS  Google Scholar 

  21. Booij L, Van der Does W, Benkelfat C, Bremner JD, Cowen PJ, Fava M, Gillin C, Leyton M, Moore P, Smith KA, Van der Kloot WA (2002) Predictors of mood response to acute tryptophan depletion: a reanalysis. Neuropsychopharmacology 27:852–861

    Article  PubMed  CAS  Google Scholar 

  22. Hobson JA, McCarley RW, Wyzinski PW (1975) Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189:55–58

    Article  PubMed  CAS  Google Scholar 

  23. Bhatti T, Gillin JC, Seifritz E, Moore P, Clark C, Golshan S, Stahl S, Rapaport M, Kelsoe J (1998) Effects of a tryptophan-free amino acid drink challenge on normal human sleep EEG and mood. Biol Psychiatry 43:52–59

    Article  PubMed  CAS  Google Scholar 

  24. Moore P, Gillin JC, Bhatti T, DeModena A, Seifritz E, Clark C, Stahl S, Rapaport M, Kelsoe J (1998) Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 55:534–539

    Article  PubMed  CAS  Google Scholar 

  25. Voderholzer U, Hornyak M, Thiel B, Huwig-Poppe C, Kiemen A, König A, Backhaus J, Riemann D, Berger M, Hohagen F (1998) Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18:112–124

    Article  PubMed  CAS  Google Scholar 

  26. Riemann D, Feige B, Hornyak M, Koch S, Hohagen F, Voderholzer U (2002) The tryptophan-depletion test: impact on sleep in primary insomnia—a pilot study. Psychiatry Res 109:129–135

    Article  PubMed  CAS  Google Scholar 

  27. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 49:651–668

    PubMed  CAS  Google Scholar 

  28. Riemann D, Berger M, Voderholzer U (2001) Sleep and depression—results from psychobiological studies: an overview. Biol Psychiatry 57:67–103

    Article  CAS  Google Scholar 

  29. Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein R, Murphy DL (1982) Sleep in obsessive-compulsive disorder. Arch Gen Psychiatry 93:1372–1377

    Google Scholar 

  30. Walsleben J, Robinson D, Lemus C, Hackshaw R, Norman R, Alvir J (1990) Polysomnographic aspects of obsessive-compulsive disorders. Sleep Res 19:177

    Google Scholar 

  31. Hohagen F, Lis S, Krieger S, Winkelmann G, Riemann D, Fritsch Montero R, Rey E, Aldenhoff J, Berger M (1994) Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 243:273–278

    Article  PubMed  CAS  Google Scholar 

  32. Robinson D, Walsleben J, Pollack S, Lerner G (1998) Nocturnal polysomnography in obsessive-compulsive disorder. Psychiatry Res 80:257–263

    Article  PubMed  CAS  Google Scholar 

  33. Spitzer RL, Williams JB, Gibbons M (1984) The structured clinical interview for DSM-III-R. Biometrics Research Department, New York State Psychiatric Institute, New York

    Google Scholar 

  34. Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour B, Kleig J, Horn R (1988) Strukturiertes klinisches Interview für DSM-III-R (SKID-P). Beltz-Test, Weinheim

  35. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989a) The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 46:1012–1016

    CAS  Google Scholar 

  36. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989b) The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 46:1006–1011

    CAS  Google Scholar 

  37. Büttner-Westphal H, Hand I (1991) Yale-Brown Obsessive Compulsive Scale, Deutsche Übersetzung und Bearbeitung. Verhaltenstherapie 1:226–233

    Article  Google Scholar 

  38. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Government Printing Office, Public Health Service, Washington, DC

    Google Scholar 

  39. Delgado P, Charney D, Price L, Aghajanian G, Landis H, Heninger G (1990) Serotonin and the Mechanism of Antidepressant Action. Arch Gen Psychiatry 47:411–418

    PubMed  CAS  Google Scholar 

  40. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173–177

    Article  PubMed  CAS  Google Scholar 

  41. Delgado P, Price S, Miller H, Salomon R, Aghajanian G, Heninger F, Charney D (1994) Serotonin and the Neurobiology of Depression. Effects of Tryptophan Depletion in Drug-Free Depressed Patients. Arch Gen Psychiatry 51:865–874

    PubMed  CAS  Google Scholar 

  42. Zerssen von D (1986) Clinical Self-Rating Scales (CSRS) of the Munich Psychiatry Information System (PSYCHIS München). In: Sartorius N, Ban TA (eds). Assessment of Depression. Springer, Berlin Heidelberg New York, Tokyo, pp 270–303

    Google Scholar 

  43. Bech P, Gram LF, Dein E, Jacobson O, Vitger J, Bohuys TG (1975) Quantitative ratings of depressive states. Acta Psychiatrica Scand 51:161–170

    CAS  Google Scholar 

  44. Saletu-Zyhlarz G, Saletu G, Anderer P, Brandstatter N, Frey R, Gruber G, Klosch G, Mandl M, Grunberger J, Linzmayer L (1997) Nonorganic insomnia in generalized anxiety disorder. Neuropsychobiol 36:117–129

    Article  CAS  Google Scholar 

  45. Stein MB, Enns MW, Kryger MH (1993) Sleep in nondepressed patients with panic disorder: II. polysomnographic assessment of sleep architecture and sleep continuity. J Affect Dis 28:1–6

    Article  PubMed  CAS  Google Scholar 

  46. Uhde TW, Roy-Byrne P, Gilling JC, Mendelson WB, Boulenger JP, Vittone BJ, Post RM (1984) The sleep of patients with panic disorder: a preliminary report. Psychiatry Res 12:251–259

    Article  PubMed  CAS  Google Scholar 

  47. Brown TM, Black B, Uhde TW (1994) The sleep architecture of social phobia. Biol Psychiatry 35:420–421

    Article  PubMed  CAS  Google Scholar 

  48. Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, John U (2001) Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 251: 130–135

    Article  PubMed  CAS  Google Scholar 

  49. Keshavan MS, Tandon R (1993) Sleep abnormalities in schizophrenia: Pathophysiological significance. Psychol Med 23:831–835

    Article  PubMed  CAS  Google Scholar 

  50. Gillin JC, Smith TL, Irwin M, Kripke DF, Brown S, Schuckit M (1990) Short REM latency in primary alcoholic patients with secondary depression. Am J Psychiatry 147:106–109

    PubMed  CAS  Google Scholar 

  51. Moore P, Seifritz E, Schlosser A, Greenfield D, Stahl S, Rapaport M, Kelsoe J (2001) Rapid tryptophan depletion plus a serotonin 1A agonist: competing effects on sleep in healthy men. Neuropsychopharmacol 25:S40–S44

    Article  CAS  Google Scholar 

  52. Jouvet M (1969) Biogenic amines and the states of sleep. Science 163:32–41

    Article  PubMed  CAS  Google Scholar 

  53. Siegel JM (2000) Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC (eds) Priciples and Practice of Sleep Medicine, 3rd edn. W.B. Saunders Company, Philadelphia, London, Toronto, pp 112–133

    Google Scholar 

  54. Koella WP, Feldstein A, Czicman JS (1968) The effect of p-chlorophenylalanine on the sleep of cats. Electroencephalogr Clin Neurophysiol 25:481–490

    Article  PubMed  CAS  Google Scholar 

  55. Weitzman ED, Rapport MM, McGregor P, Jacoby J (1968) Sleep patterns of the monkey and brain serotonin concentration: effect of p-chlorophenylalanine. Science 160:1361–1363

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Gerda Deeb, Claudine Heinrich and Evelyne Hoffmann for careful analysis of polysomnographic recordings, Sabine Ecker for statistical analysis, and Gerald Huether for determination of serum tryptophan concentrations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich Voderholzer MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voderholzer, U., Riemann, D., Huwig-Poppe, C. et al. Sleep in obsessive compulsive disorder. Eur Arch Psychiatry Clin Neurosci 257, 173–182 (2007). https://doi.org/10.1007/s00406-006-0708-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-006-0708-9

Key words

Navigation